Drug trafficking is a highly profitable commercial activity and remains a core business for organised crime groups across Europe today. Understanding the reality of the European drug market requires a holistic approach, following the supply chain from production and trafficking to distribution and sales.
Taking such an approach, two EU agencies — the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol — have joined forces to provide their third state-of-the art overview of the European illicit drug market in the 2019 EU Drug Markets Report.
To be launched in Brussels on 26 November, this strategic and action-oriented analysis combines data from the EMCDDA’s drug monitoring system with Europol’s operational intelligence on organised crime.
The 250-page graphic-rich report (including an executive summary) is accompanied by 12 supporting papers addressing gaps identified in the 2016 edition.
A news release, with the main highlights, will be available in 24 languages, while graphics will be downloadable from an online media library.
Date: 26 November 2019
Time: 10.00 Central European Time (CET/Brussels); 09.00 (WET/Lisbon)
Venue: Résidence Palace, International Press Centre, 155 Rue de la Loi, B-1040 Brussels.
RSVP and embargoed copies: firstname.lastname@example.org
- European Commission spokespersons’ service — Tel. (32) 2 298 67 64 (Tove Ernst); Tel. (32) 2 296 34 44 (Katarzyna Kolanko)
- EMCDDA press office: email@example.com — Tel. (351) 211 21 02 00/40
- Europol press office: firstname.lastname@example.org — Tel. (31) 703 02 50 01
The EU Drug Markets Report is published every three years.